Crossmark

APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFα expression and signalling

Crossref DOI link: https://doi.org/10.1007/s10787-020-00715-5

Published Online: 2020-05-07

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cross, A. L.

Hawkes, J.

Wright, H. L.

Moots, R. J.

Edwards, S. W. https://orcid.org/0000-0002-7074-0552
Funding

Funding for this research was provided by:

AKL Research and Development Ltd.
License Information

Text and Data Mining valid from 2020-05-07

Version of Record valid from 2020-05-07
More Information

Article History

Received: 1 April 2020

Accepted: 24 April 2020

First Online: 7 May 2020

Compliance with ethical standards

:

: NHS Health Research Authority (Inflammatory Signalling Pathways; Ref 11/NW/0206: IRAS project ID 75388). The authors declare that there were no conflicts of interest.

Document is current

Any future updates will be listed below